HBL - Hadasit Bio-Holdings Valuation
Is HDST-M undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HDST-M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate HDST-M's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate HDST-M's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HDST-M?
Other financial metrics that can be useful for relative valuation.
What is HDST-M's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₪5.99m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does HDST-M's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.7x | ||
SMAG Smart Agro - | 0.2x | n/a | ₪8.7m |
PLNT PlantArc Bio | 0.7x | n/a | ₪9.1m |
UNVO Univo Pharmaceuticals | 0.2x | n/a | ₪2.8m |
CANF Can-Fite BioPharma | 1.7x | -3.5% | ₪40.4m |
HDST-M HBL - Hadasit Bio-Holdings | 1x | n/a | ₪6.0m |
Price-To-Book vs Peers: HDST-M is expensive based on its Price-To-Book Ratio (1x) compared to the peer average (0.9x).
Price to Earnings Ratio vs Industry
How does HDST-M's PE Ratio compare vs other companies in the Asian Biotechs Industry?
Price-To-Book vs Industry: HDST-M is good value based on its Price-To-Book Ratio (1x) compared to the Asian Biotechs industry average (2.8x).
Price to Book Ratio vs Fair Ratio
What is HDST-M's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | 1x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate HDST-M's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.